Steven Michael Mintz

Steven Michael Mintz appears in our data through filings on Portage Biotech Inc. shares, published by SEDI. We count 41 filings; the first trade dates from 6 April 2016 and the latest from 7 March 2022.

Market trades split into 3 purchases (€56k) and 11 sales. No amount is published for 11 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 2 option exercises. So far in 2022, the count stands at 2 purchases and no sales.

The median purchase comes to €6,091. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The latest filing, published on 12 March 2022, reports an open-market purchase of €4,035 in Portage Biotech Inc. Between a trade and the moment it shows up on SEDI, the median delay is 5 days. This delay matters because a trade only becomes useful information once it is public. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEDI. Past trades are no guide to future returns.